Clinical Trial Update: Combination With Gemcitabine in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating combination therapy with gemcitabine in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Bayer | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED